Jeff Yass’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Jeff Yass’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-393,563	Closed	-$866K	–	14866
2022 Q2	$866K	Buy	393,563 +376,187	+2,165%	+$751K	﹤0.01%	6889
2022 Q1	$32K	Sell	17,376 -47,970	-73%	-$87.3K	﹤0.01%	12489
2021 Q4	$143K	Buy	+65,346	New	+$177K	﹤0.01%	11850

Jeff Yass's ETTX Position: Q3 2022 in Review

Jeff Yass sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 393,563 shares — an estimated $866K sold.

Jeff Yass first reported a position in ETTX in Q4 2021 and held it in 3 quarters. The position peaked at $866K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Jeff Yass reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Jeff Yass sold 393,563 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $866K.
Jeff Yass first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2021 and held it in 3 quarters.
Jeff Yass's Entasis Therapeutics Holdings Inc. position peaked at $866K in Q2 2022.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.